Liver-targeting vaccine protects mice from allergic asthma reactions for at least a year
An “inverse vaccine” that delivers deactivated allergens to the liver was able to reduce reactions in mice with allergic asthma for at least a year after treatment. Should the approach translate to humans, people with allergies may one day be able to take a vaccine that protects them from dangerous allergic reactions.
An “inverse vaccine” that delivers deactivated allergens to the liver was able to reduce reactions in mice with allergic asthma for at least a year after treatment. Should the approach translate to humans, people with allergies may one day be able to take a vaccine that protects them from dangerous allergic reactions.
